NICA Stock Overview
A nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science applications worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Nanologica AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 1.93 |
| 52 Week High | SEK 10.65 |
| 52 Week Low | SEK 1.63 |
| Beta | 0.42 |
| 1 Month Change | 5.77% |
| 3 Month Change | -19.79% |
| 1 Year Change | -80.67% |
| 3 Year Change | -85.19% |
| 5 Year Change | -81.13% |
| Change since IPO | -91.21% |
Recent News & Updates
Recent updates
Nanologica (STO:NICA) Is Making Moderate Use Of Debt
Oct 10
Is Nanologica AB (publ) (STO:NICA) Trading At A 40% Discount?
Jun 12Does Nanologica (STO:NICA) Have A Healthy Balance Sheet?
Oct 20Nanologica (STO:NICA) Is Making Moderate Use Of Debt
Jun 23Is Nanologica (NGM:NICA) A Risky Investment?
Jan 03Is Nanologica (NGM:NICA) Weighed On By Its Debt Load?
Jun 14Shareholders Are Thrilled That The Nanologica (NGM:NICA) Share Price Increased 115%
Feb 23Shareholder Returns
| NICA | SE Biotechs | SE Market | |
|---|---|---|---|
| 7D | 7.8% | 1.2% | -2.7% |
| 1Y | -80.7% | 13.8% | 4.6% |
Return vs Industry: NICA underperformed the Swedish Biotechs industry which returned 13.8% over the past year.
Return vs Market: NICA underperformed the Swedish Market which returned 4.6% over the past year.
Price Volatility
| NICA volatility | |
|---|---|
| NICA Average Weekly Movement | 10.2% |
| Biotechs Industry Average Movement | 9.9% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in SE Market | 11.3% |
| 10% least volatile stocks in SE Market | 3.2% |
Stable Share Price: NICA's share price has been volatile over the past 3 months compared to the Swedish market.
Volatility Over Time: NICA's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 16 | Andreas Bhagwani | www.nanologica.com |
Nanologica AB (publ), a nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science applications worldwide. The company operates through two segments, Drug Development and Chromatography. It offers NLAB Saga, a new generation silica for preparative chromatography; and SVEA HPLC analytical columns.
Nanologica AB (publ) Fundamentals Summary
| NICA fundamental statistics | |
|---|---|
| Market cap | SEK 170.09m |
| Earnings (TTM) | -SEK 88.43m |
| Revenue (TTM) | SEK 8.76m |
19.4x
P/S Ratio-1.9x
P/E RatioIs NICA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NICA income statement (TTM) | |
|---|---|
| Revenue | SEK 8.76m |
| Cost of Revenue | SEK 7.44m |
| Gross Profit | SEK 1.33m |
| Other Expenses | SEK 89.76m |
| Earnings | -SEK 88.43m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 07, 2025
| Earnings per share (EPS) | -1.00 |
| Gross Margin | 15.15% |
| Net Profit Margin | -1,009.07% |
| Debt/Equity Ratio | -0.3% |
How did NICA perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 06:00 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Nanologica AB (publ) is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Filip Einarsson | Redeye |